All News #Library
Others
Merck Signs Agreement with Dr. Falk Pharma GmbH for MK-8690
04 Nov 2025 //
PRESS RELEASE
Renexxion, Dr. Falk Complete Ph2b Gastroparesis Trial
27 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma reports positive phase 3 trial on norucholic acid
07 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma Acquires Kynos, Focuses on Acute Pancreatitis
29 Oct 2024 //
ACCESSWIRE

Market Place
Sourcing Support